Updates

Get Alerts
September 4, 2024 | Harrison's Online Updates
Effect of Semaglutide on Chronic Kidney Disease
J. Larry Jameson
July 30, 2024 | Harrison's Online Updates
Antiamyloid Antibody Therapy in Alzheimer’s Disease
Peter A. Ljubenkov, Gil D. Rabinovici
July 23, 2024 | Harrison's Online Updates
Continuous β-lactam Antibiotic Infusion Is Better Than Intermittent Dosing in Patients with Sepsis
Neeraj K. Surana
June 5, 2024 | Harrison's Online Updates
Current AI Algorithms Cannot Replace Infectious Disease Physicians
Neeraj K. Surana
May 22, 2024 | Hurst's the Heart Updates
A Double-Blind, Randomized Placebo-Procedure-Controlled Trial of an Interatrial Shunt in Patients with HFrEF and HFpEF - RELIEVE-HF
Lindsey R. Mitrani, Anu Lala
May 22, 2024 | Hurst's the Heart Updates
PREVENT Trial: Impact of Percutaneous Coronary Intervention in Patients with Vulnerable Non-Obstructive Coronary Plaques
Kyle F. Nelson, Gina LaRocca
May 22, 2024 | Hurst's the Heart Updates
Phase 2 KARDIA-2 Trial
Stephanie Jou, Jeffrey I. Mechanick
May 22, 2024 | Hurst's the Heart Updates
ORBITA-COSMIC: Coronary Sinus Reducer for the Treatment of Refractory Angina
Sean R. Mendez, Gregory Serrao
May 22, 2024 | Hurst's the Heart Updates
IMPROVE-HCM Trial: A Safe Novel Agent for Nonobstructive Hypertrophic Cardiomyopathy
Ashton C. Lai, Martin E. Goldman
May 22, 2024 | Hurst's the Heart Updates
EMPACT-MI Trial Review
Krishan Sharma, Tara Naib
May 22, 2024 | Hurst's the Heart Updates
DanGer Shock
Jason Feinman, Matthew Tomey
May 22, 2024 | Hurst's the Heart Updates
AEGIS-II Trial: Apolipoprotein A1 Infusions and Cardiovascular Outcomes after Acute Myocardial Infarction
Chris Song, Daniella Kadian-Dodov
April 24, 2024 | Harrison's Online Updates
Cardiac Resynchronization Therapy in Heart Failure
Amy Miller, Joseph Loscalzo
April 24, 2024 | Harrison's Online Updates
Interventional Management of Infrapopliteal Disease
Amy Miller, Joseph Loscalzo
April 22, 2024 | Harrison's Online Updates
Impact of Smoking Cessation on Short- and Longer-Term Mortality
Rebecca Baron, Joseph Loscalzo
April 22, 2024 | Harrison's Online Updates
Nirmatrelvir–Ritonavir Is Not Effective for Individuals at Standard Risk for Severe COVID-19
Neeraj K. Surana
February 12, 2024 | Harrison's Online Updates
Non-Small Cell Lung Cancer with EGFR Mutations
Dan L. Longo
December 20, 2023 | Hurst's the Heart Updates
SELECT Trial: Semaglutide in the High-Risk Non-Diabetic Obese Population
Ashton C. Lai, Jeffrey I. Mechanick
December 20, 2023 | Hurst's the Heart Updates
ORBITA-2
Jason Feinman, Matthew Tomey
December 20, 2023 | Hurst's the Heart Updates
Lepodisiran, an Extended-Duration Short Interfering RNA Targeting Lipoprotein(a): A Randomized Dose-Ascending Clinical Trial
Chris Song, Greg Serrao
December 20, 2023 | Hurst's the Heart Updates
Sustained Blood Pressure Reduction With the RNA Interference Therapeutic Zilebesiran: Primary Results From KARDIA-1, a Phase 2 Study in Patients With Hypertension
Sean R. Mendez, Javier Sanz
December 20, 2023 | Hurst's the Heart Updates
Safety and Pharmacodynamic Effects of VERVE-101, an Investigational DNA Base Editing Medicine Designed to Durably Inactivate the PCSK9 Gene and Lower LDL Cholesterol - Interim Results of the Phase 1b Heart-1 Trial
Stephanie Jou, Tara Naib
December 20, 2023 | Hurst's the Heart Updates
A Multicenter, RandomiZed, Active-ControLled Study to Evaluate the Safety and Tolerability of Two Blinded Doses of Abelacimab Compared With Open-Label Rivaroxaban in Patients With Atrial Fibrillation - AZALEA-TIMI 71
Lindsey R. Mitrani, Jacob Koruth
December 20, 2023 | Hurst's the Heart Updates
ARTESIA: Apixaban for Stroke Prevention in Subclinical Atrial Fibrillation
Lindsey R. Mitrani, Daniella Kadian-Dodov
November 29, 2023 | Harrison's Online Updates
Apixaban for Stroke Prevention in Patients with Subclinical Atrial Fibrillation
Amy Miller, Joseph Loscalzo